{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:50:07Z","timestamp":1760622607975},"reference-count":16,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"published-print":{"date-parts":[[1982,9,1]]},"DOI":"10.1136\/hrt.48.3.272","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T21:46:00Z","timestamp":1190151960000},"page":"272-277","source":"Crossref","is-referenced-by-count":46,"title":["Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment."],"prefix":"10.1136","volume":"48","author":[{"given":"S","family":"Rich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K M","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"112","article-title":"Hope in primary pulmonary hypertension?","volume":"302","author":"Reeves, J.T.","year":"1980","unstructured":"Reeves JT. Hope in primary pulmonary hypertension?N Engl7Med 1980; 302: 112-3."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJM197612162952506","article-title":"Primary pulmonary hypertension. Favorable effect of isoproterenol","volume":"295","author":"Shettigar, U.R.; Hultgren, H.N.; Specter, M.; Martin, R.; Davies, D.H.","year":"1976","unstructured":"Shettigar UR, Hultgren HN, Specter M, Martin R, Davies DH. Primary pulmonary hypertension. Favorable effect of isoproterenol. N Engl J Med 1976; 295: 1414-5.","journal-title":"N Engl J Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"772","DOI":"10.7326\/0003-4819-90-5-772","article-title":"Primary pulmonary hypertension treated with oral phentolamine","volume":"90","author":"Ruskin, J.N.; AM, Jr, Hutter","year":"1979","unstructured":"Ruskin JN, Hutter AM Jr. Primary pulmonary hypertension treated with oral phentolamine. Ann Intem Med 1979; 90: 772-4.","journal-title":"Ann Intem Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/hrt.44.3.352","article-title":"Primary pulmonary hypertension: effects of nifedipine","volume":"44","author":"Camerini, F.; Alberti, E.; Klugmann, S.; Salvi, A.","year":"1980","unstructured":"Camerini F, Alberti E, Klugmann S, Salvi A. Primary pulmonary hypertension: effects of nifedipine. Br Heart J 1980; 44: 352-6.","journal-title":"Br Heart J"},{"key":"ref_5","article-title":"A reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response","author":"Rich, S.; Martinez, J.; Lam, W.; Rosen, K.M.","unstructured":"Rich S, Martinez J, Lam W, Rosen KM. A reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response. Am Heart Jf (in press).","journal-title":"Am Heart Jf"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0002-9343(76)90889-5","article-title":"Conversion of angiotensin I to angiotensin II","volume":"60","author":"Erdos, E.G.","year":"1976","unstructured":"Erdos EG. Conversion of angiotensin I to angiotensin II. Am J Med 1976; 60: 749-59.","journal-title":"Am J Med"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0033-0620(78)90024-5","article-title":"Captopril (SQ 14,225) (D-3 mercapto- 2-methylpropanoyl-L-proline): a novel orally active inhibitor of angiotensin convertingenzyme and antihypertensive agent","volume":"21","author":"Rubin, B.; Antonaccio, M.J.; Horovitz, Z.P.","year":"1978","unstructured":"Rubin B, Antonaccio MJ, Horovitz ZP. Captopril (SQ 14,225) (D-3 mercapto-2-methylpropanoyl-L-proline): a novel orally active inhibitor of angiotensin convertingenzyme and antihypertensive agent. Prog Cardiovasc Dis 1978; 21: 183-94.","journal-title":"Prog Cardiovasc Dis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJM197805042981803","article-title":"Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14,225 in man","volume":"298","author":"Gavras, H.; Brunner, H.R.; Turini, G.A.","year":"1978","unstructured":"Gavras H, Brunner HR, Turini GA, et al. Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14,225 in man. N Engl J Med 1978; 298: 991-5.","journal-title":"N Engl J Med"},{"key":"ref_9","first-page":"117","article-title":"Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensinconverting enzyme","volume":"301","author":"Davis, R.; Ribner, H.S.; Keung, E.; Sonnenblick, E.H.; LeJemtel, T.H.","year":"1979","unstructured":"Davis R, Ribner HS, Keung E, Sonnenblick EH, LeJemtel TH. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensinconverting enzyme. N Engl7Med 1979; 301: 117-21."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0002-9343(79)90735-6","article-title":"Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in man","volume":"67","author":"Niarchos, A.P.; Roberts, A.J.; Laragh, J.H.","year":"1979","unstructured":"Niarchos AP, Roberts AJ, Laragh JH. Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in man. Am J Med 1979; 67: 785-91.","journal-title":"Am J Med"},{"key":"ref_11","first-page":"125764","article-title":"Captopril-induced changes in prostaglandin production. Relationship to vascular responses in normal man","volume":"65","author":"Swartz, S.L.; Williams, G.H.; Hollenberg, N.K.; Levine, L.; Dluhy, R.G.; Moore, T.J.","year":"1980","unstructured":"Swartz SL, Williams GH, Hollenberg NK, Levine L, Dluhy RG, Moore TJ. Captopril-induced changes in prostaglandin production. Relationship to vascular responses in normal man. Clin Invest 1980; 65: 125764.","journal-title":"Clin Invest"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-90-1-19","article-title":"Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients","volume":"90","author":"Brunner, H.R.; Gavras, H.; Waeber, B.","year":"1979","unstructured":"Brunner HR, Gavras H, Waeber B, et al. Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients. Ann Intem Med 1979; 90: 19-23.","journal-title":"Ann Intem Med"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0002-8703(80)90730-9","article-title":"Captopril in severe treatment-resistant hypertension","volume":"99","year":"1980","unstructured":"Ferguson P.K, Vlasses PH, Koplin JR, Shirinian A, Burke JF Jr, Alexander JC. Captopril in severe treatment-resistant hypertension. Am Heart J 1980; 99: 579-85.","journal-title":"Am Heart J"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.CIR.62.1.35","article-title":"Acute and long term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure","volume":"62","author":"Levine, T.B.; Franciosa, J.A.; Cohn, J.N.","year":"1980","unstructured":"Levine TB, Franciosa JA, Cohn JN. Acute and long term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure. Circulation 1980; 62: 35-41.","journal-title":"Circulation"},{"key":"ref_15","first-page":"573","article-title":"Primary pulmonary hypertension","volume-title":"vascular diseases","author":"Voelkel, N.; Reeves, J.T.","year":"1979","unstructured":"Voelkel N, Reeves JT. Primary pulmonary hypertension. In: Moser KM, ed. Pulmonary vascular diseases. New York, Basel: Marcel Dekker, 1979: 573-628."},{"key":"ref_16","first-page":"53347","article-title":"The pathology of hypertensive pulmonary vascular disease. A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects","volume":"18","author":"Heath, D.; Edwards, J.E.","year":"1958","unstructured":"Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease. A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958; 18: 53347.","journal-title":"Circulation"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.48.3.272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T00:55:57Z","timestamp":1601081757000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.48.3.272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,9,1]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1982,9,1]]}},"URL":"https:\/\/doi.org\/10.1136\/hrt.48.3.272","relation":{},"ISSN":["1355-6037"],"issn-type":[{"value":"1355-6037","type":"print"}],"subject":[],"published":{"date-parts":[[1982,9,1]]}}}